Age-specific mortality rates (ASMR) were highest in adults aged 65 years or older (4.736 per 100 000 in 2019; 95% CI, and adults aged 45 to 64 years (2.726 in 2019; 95% CI, 2.613-2.838) (Figure, B). The ASMRs in adults aged 65 years or older decreased from 2001 to 2006 and stabilized from 2006 to 2014, followed by an increase from 2014 to 2019 (APC, 6.0%; 95% CI, 3.3%-8.7%; P < .001). High ADI counties experienced decreasing AAMRs from 1999 to 2010, with increasing AAMRs from 2010 to 2019 (APC, 5.6%; 95% CI, 4.3%-7.0%; P < .001) (Table). From logistic regression, the AAMR in high ADI counties (2.214 per 100 000; 95% CI, 2.025-2.402) was greater than low ADI counties (1.461; 95% CI, 1.414-1.509; P < .001) in 2019 (Figure, C). Mortality increased following onset of the COVID-19 pandemic in 2020 and 2021 overall and among all subgroups and decreased in 2022. Mortality peaked in 2021 with 10 230 deaths (AAMR, 2.710 deaths per 100 000; 95% CI, 2.656-2.764) overall and decreased to 8707 deaths in 2022 (AAMR, 2.307; 95% CI, 2.258-2.357).Discussion | Mortality due to DKA and hyperosmolar hyperglycemic state increased from 1999 to 2019 with disparities by age and area deprivation. The etiology of this upward trend in mortality is likely multifactorial, and interpretation of 2020 to 2022 data is complicated by the COVID-19 pandemic. Inadequate preventive care, disproportionately affecting disadvantaged populations and exacerbated by the pandemic, likely contributes to these findings. Recent practice trends seeking to avoid hypoglycemia by relaxing glycemic targets may have led to an increased risk of hyperglycemia. 3,4 Sodium-glucose cotransporter 2 inhibitors, first approved in 2013, are associated with increased risk of DKA and may also play a role in these results. 6 This analysis is limited by a reliance on death certificates, which may be miscoded. These findings suggest a need for further investigation to understand the causes behind increasing deaths due to hyperglycemic crisis.